Carl Zeiss Meditec AG Share Price Berne S.E.

Equities

AFX

DE0005313704

Advanced Medical Equipment & Technology

Delayed Berne S.E. 09:30:00 08/04/2024 pm IST 5-day change 1st Jan Change
104.7 CHF -10.65% Intraday chart for Carl Zeiss Meditec AG -10.65% +12.25%

Financials

Sales 2024 * 2.23B 2.42B 2.21B 201B Sales 2025 * 2.51B 2.72B 2.49B 226B Capitalization 8.26B 8.96B 8.19B 744B
Net income 2024 * 255M 277M 253M 22.97B Net income 2025 * 316M 343M 313M 28.47B EV / Sales 2024 * 3.88 x
Net Debt 2024 * 396M 429M 392M 35.65B Net Debt 2025 * 345M 374M 342M 31.08B EV / Sales 2025 * 3.43 x
P/E ratio 2024 *
32.4 x
P/E ratio 2025 *
26.1 x
Employees -
Yield 2024 *
1.14%
Yield 2025 *
1.3%
Free-Float 40.86%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 51 31/21/31
Director of Finance/CFO 59 01/18/01
Director/Board Member 57 15/09/15
Members of the board TitleAgeSince
Director/Board Member 66 01/02/01
Director/Board Member 55 27/21/27
Director/Board Member 52 22/23/22
More insiders
Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The Company has various production sites in Europe, the United States and Asia.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
92.35 EUR
Average target price
104.2 EUR
Spread / Average Target
+12.83%
Consensus